J. Biochem, 1990, Vol. 108, No. 2 250-254
© 1990 Japanese Biochemical Society
research-article |
Purification and Properties of Multiple Forms of Dihydrodiol Dehydrogenase from Human Liver1
Department of Biochemistry, Gifu Pharmaceutical University Gifu Gifu 502
2To whom correspondence should be addressed
Two acidic and three basic forms of monomeric dihydrodiol dehydrogenase with molecular weights in the range of 38,000–39,000 were purified from human liver. One acidic enzyme (pI 5.2), which was specific for NADP+ and dihydrodiols of benzene and naphthalene, was immunologically identified as aldehyde reductase. The other four enzymes oxidized alicyclic alcohols as well as the dihydrodiols using both NADP+ and NAD+ as cofactors, but showed differences in specificity for hydroxysteroids and inhibitor sensitivity. Two of the basic enzymes (pI 9.7 and 9.1) exhibited a 20
-hydroxysteroid dehydrogenase activity and sensitivity to 1,10-phenanthroline, whereas the third basic enzyme (pI 7.6) oxidized some 3a-hydroxysterolds at low rates and was inhibited by cyclopentane-1,1-diacetic acid. Another acidic enzyme, which accounted for the largest amount of enzyme activity in the tissue and appeared in two heterogenous forms with p1 values of 5.9 and 5.4, showed a high 3a-hydroxysteroid dehydrogenase activity and was the most sensitive to inhibition by medroxyprogesterone acetate. The K values of the enzymes, except the pI 5.2 enzyme, for hydroxysteroids (10–6 to 10– M) were lower than those for xenobiotic alcohols.
1This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. Lou, S. Du, Q. Ji, and A. Stolz Induction of AKR1C2 by Phase II Inducers: Identification of a Distal Consensus Antioxidant Response Element Regulated by NRF2 Mol. Pharmacol., May 1, 2006; 69(5): 1662 - 1672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-J. Martin, U. Breyer-Pfaff, V. Wsol, S. Venz, S. Block, and E. Maser PURIFICATION AND CHARACTERIZATION OF AKR1B10 FROM HUMAN LIVER: ROLE IN CARBONYL REDUCTION OF XENOBIOTICS Drug Metab. Dispos., March 1, 2006; 34(3): 464 - 470. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L. Rizner, H. K. Lin, D. M. Peehl, S. Steckelbroeck, D. R. Bauman, and T. M. Penning Human Type 3 3{alpha}-Hydroxysteroid Dehydrogenase (Aldo-Keto Reductase 1C2) and Androgen Metabolism in Prostate Cells Endocrinology, July 1, 2003; 144(7): 2922 - 2932. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Vergnes, J. Phan, A. Stolz, and K. Reue A cluster of eight hydroxysteroid dehydrogenase genes belonging to the aldo-keto reductase supergene family on mouse chromosome 13 J. Lipid Res., March 1, 2003; 44(3): 503 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Dufort, F. Labrie, and V. Luu-The Human Types 1 and 3 3{{alpha}}-Hydroxysteroid Dehydrogenases: Differential Lability and Tissue Distribution J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 841 - 846. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. E. Burczynski, H.-K. Lin, and T. M. Penning Isoform-specific Induction of a Human Aldo-Keto Reductase by Polycyclic Aromatic Hydrocarbons (PAHs), Electrophiles, and Oxidative Stress: Implications for the Alternative Pathway of PAH Activation Catalyzed by Human Dihydrodiol Dehydrogenase Cancer Res., February 1, 1999; 59(3): 607 - 614. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Suzuki, Y. Fujii, M. Miyano, L.-Y. Chen, T. Takahashi, and K. Watanabe cDNA Cloning, Expression, and Mutagenesis Study of Liver-type Prostaglandin F Synthase J. Biol. Chem., January 1, 1999; 274(1): 241 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Matsuura, A. Hara, M. Kato, Y. Deyashiki, Y. Miyabe, S. Ishikura, T. Sugiyama, and Y. Katagiri Activation of Human Liver 3alpha -Hydroxysteroid Dehydrogenase by Clofibrate Derivatives J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1096 - 1103. [Abstract] [Full Text]
|
|
|
|
 |
|
 H.-K. Lin, J. M. Jez, B. P. Schlegel, D. M. Peehl, J. A. Pachter, and T. M. Penning Expression and Characterization of Recombinant Type 2 3{alpha}-Hydroxysteroid Dehydrogenase (HSD) from Human Prostate: Demonstration of Bifunctional 3{alpha}/17{beta}-HSD Activity and Cellular Distribution Mol. Endocrinol., December 1, 1997; 11(13): 1971 - 1984. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Penning Molecular Endocrinology of Hydroxysteroid Dehydrogenases Endocr. Rev., June 1, 1997; 18(3): 281 - 305. [Abstract] [Full Text]
|
|